Skip to main navigation MENU Home Investors Investors Q3 2021 Syneos Health Inc. Earnings Conference Call SCROLL OVERVIEW NEWS & EVENTS STOCK PERFORMANCE CORPORATE GOVERNANCE FINANCIALS INVESTOR RESOURCES News Releases Syneos Health to Present at Upcoming Investor Conferences Nov 11, 2021 Discover More Email Alerts Events & Presentations Syneos Health at the Evercore ISI 4th Annual HealthCONx Conference Dec 1, 2021 at 4:20 PM EST Discover More Q3 2021 Results Earnings Release Form 10-Q Earnings Call Presentation Discover More Data Provided by Refinitiv. Minimum 15 minutes delayed. Discover More Corporate Governance Management Team View Now Board of Directors View Now Committee Composition View Now Syneos Health fully expresses our value proposition – that is, our ability to deliver integrated end-to-end solutions and create new paths for our customers to develop and commercialize their therapies Alistair Macdonald CEO Meet Our CEO Sign Up for Email Alerts Subscribe Now Interested in Syneos Health? Get In Touch Connect About Syneos Health Syneos Health® (Nasdaq:SYNH) is the only fully integrated biopharmaceutical solutions organization. Our Company, including a Contract Research Organization (CRO) and Contract Commercial Organization (CCO), is purpose-built to accelerate customer performance to address modern market realities. Created through the merger of two industry leading companies – INC Research and inVentiv Health – we bring together approximately 26,000 clinical and commercial minds with the ability to support customers in more than 110 countries. Contact Us Corporate Headquarters 1030 Sync Street Morrisville, NC 27560 Phone:+1 919 876 9300 Fax:+1 919 876 9360 Toll-free:+1 866 462 7373 Solutions Therapeutic Expertise Brand Directory Careers Study Participants Media Business Ethics Helpline Events Transparency © 2021 Syneos Health. All Rights Reserved. Terms Of Use Privacy Policy